166 related articles for article (PubMed ID: 15774616)
21. The impact of inflammation to the antioxidant defense parameters in AMD patients.
Čolak E; Majkić-Singh N; Žoric L; Radosavljević A; Kosanović-Jaković N
Aging Clin Exp Res; 2012 Dec; 24(6):588-94. PubMed ID: 22982945
[TBL] [Abstract][Full Text] [Related]
22. Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy.
Biancini GB; Vanzin CS; Rodrigues DB; Deon M; Ribas GS; Barschak AG; Manfredini V; Netto CB; Jardim LB; Giugliani R; Vargas CR
Biochim Biophys Acta; 2012 Feb; 1822(2):226-32. PubMed ID: 22085605
[TBL] [Abstract][Full Text] [Related]
23. The progress of inflammation and oxidative stress in patients with chronic kidney disease.
Xu G; Luo K; Liu H; Huang T; Fang X; Tu W
Ren Fail; 2015 Feb; 37(1):45-9. PubMed ID: 25375354
[TBL] [Abstract][Full Text] [Related]
24. Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients.
Kalantar-Zadeh K; McAllister CJ; Lehn RS; Lee GH; Nissenson AR; Kopple JD
Am J Kidney Dis; 2003 Oct; 42(4):761-73. PubMed ID: 14520627
[TBL] [Abstract][Full Text] [Related]
25. Anemia, inflammation and health-related quality of life in chronic kidney disease patients.
Farag YM; Keithi-Reddy SR; Mittal BV; Surana SP; Addabbo F; Goligorsky MS; Singh AK
Clin Nephrol; 2011 Jun; 75(6):524-33. PubMed ID: 21612756
[TBL] [Abstract][Full Text] [Related]
26. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
[TBL] [Abstract][Full Text] [Related]
27. Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
Trabert B; Pinto L; Hartge P; Kemp T; Black A; Sherman ME; Brinton LA; Pfeiffer RM; Shiels MS; Chaturvedi AK; Hildesheim A; Wentzensen N
Gynecol Oncol; 2014 Nov; 135(2):297-304. PubMed ID: 25158036
[TBL] [Abstract][Full Text] [Related]
28. Dilemma: Correlation Between Serum Level of Hepcidin and IL-6 in Anemic Myeloma Patients.
Ibricevic-Balic L; Icindic-Nakas E; Hasic S; Kiseljakovic E; Sofo-Hafizovic A; Balic S
Med Arch; 2016 Dec; 70(6):429-432. PubMed ID: 28210014
[TBL] [Abstract][Full Text] [Related]
29. Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer.
Tas F; Duranyildiz D; Argon A; Oğuz H; Camlica H; Yasasever V; Topuz E
Med Oncol; 2005; 22(4):353-8. PubMed ID: 16260852
[TBL] [Abstract][Full Text] [Related]
30. Higher levels of interleukin-6 in cystic fluids from patients with malignant versus benign ovarian tumors correlate with decreased hemoglobin levels and increased platelet counts.
van der Zee AG; de Cuyper EM; Limburg PC; de Bruijn HW; Hollema H; Bijzet J; Krans M; de Vries EG
Cancer; 1995 Feb; 75(4):1004-9. PubMed ID: 7842401
[TBL] [Abstract][Full Text] [Related]
31. A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor α receptor 2 levels and risk of ovarian cancer.
Poole EM; Lee IM; Ridker PM; Buring JE; Hankinson SE; Tworoger SS
Am J Epidemiol; 2013 Oct; 178(8):1256-64. PubMed ID: 23966559
[TBL] [Abstract][Full Text] [Related]
32. Interrelations among the adipocytokines leptin and adiponectin, oxidative stress and aseptic inflammation markers in pre- and early-pubertal normal-weight and obese boys.
Paltoglou G; Schoina M; Valsamakis G; Salakos N; Avloniti A; Chatzinikolaou A; Margeli A; Skevaki C; Papagianni M; Kanaka-Gantenbein C; Papassotiriou I; Chrousos GP; Fatouros IG; Mastorakos G
Endocrine; 2017 Mar; 55(3):925-933. PubMed ID: 28092067
[TBL] [Abstract][Full Text] [Related]
33. Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer.
Moradi MM; Carson LF; Weinberg B; Haney AF; Twiggs LB; Ramakrishnan S
Cancer; 1993 Oct; 72(8):2433-40. PubMed ID: 8402460
[TBL] [Abstract][Full Text] [Related]
34. Reactive oxygen species, antioxidant mechanisms, and serum cytokine levels in cancer patients: impact of an antioxidant treatment.
Mantovani G; Macciò A; Madeddu C; Mura L; Massa E; Gramignano G; Lusso MR; Murgia V; Camboni P; Ferreli L
J Environ Pathol Toxicol Oncol; 2003; 22(1):17-28. PubMed ID: 12678402
[TBL] [Abstract][Full Text] [Related]
35. Regulation of iron metabolism in the acute-phase response: interferon gamma and tumour necrosis factor alpha induce hypoferraemia, ferritin production and a decrease in circulating transferrin receptors in cancer patients.
Feelders RA; Vreugdenhil G; Eggermont AM; Kuiper-Kramer PA; van Eijk HG; Swaak AJ
Eur J Clin Invest; 1998 Jul; 28(7):520-7. PubMed ID: 9726030
[TBL] [Abstract][Full Text] [Related]
36. Relationship between routine hematological parameters, serum IL-3, IL-6 and erythropoietin and mild anemia and degree of function in the elderly.
Kamenetz Y; Beloosesky Y; Zeltzer C; Gotlieb D; Magazanik A; Fishman P; Grinblat J
Aging (Milano); 1998 Feb; 10(1):32-8. PubMed ID: 9589749
[TBL] [Abstract][Full Text] [Related]
37. Alterations in acetylcholinesterase and butyrylcholinesterase activities in chronic obstructive pulmonary disease: relationships with oxidative and inflammatory markers.
Ben Anes A; Ben Nasr H; Garrouch A; Bennour S; Bchir S; Hachana M; Benzarti M; Tabka Z; Chahed K
Mol Cell Biochem; 2018 Aug; 445(1-2):1-11. PubMed ID: 29234928
[TBL] [Abstract][Full Text] [Related]
38. Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress.
Mantovani G; Macciò A; Madeddu C; Mura L; Gramignano G; Lusso MR; Massa E; Mocci M; Serpe R
J Mol Med (Berl); 2003 Oct; 81(10):664-73. PubMed ID: 12928788
[TBL] [Abstract][Full Text] [Related]
39. The impact of antihypertensive pharmacotherapy on interplay between protein-bound uremic toxin (indoxyl sulfate) and markers of inflammation in patients with chronic kidney disease.
Kaminski TW; Pawlak K; Karbowska M; Znorko B; Mor AL; Mysliwiec M; Pawlak D
Int Urol Nephrol; 2019 Mar; 51(3):491-502. PubMed ID: 30617956
[TBL] [Abstract][Full Text] [Related]
40. Plasma immune analytes in patients with epithelial ovarian cancer.
Block MS; Maurer MJ; Goergen K; Kalli KR; Erskine CL; Behrens MD; Oberg AL; Knutson KL
Cytokine; 2015 May; 73(1):108-13. PubMed ID: 25743245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
